South Korea Cell Culture Market Size & Outlook, 2026-2033
The cell culture market in South Korea is expected to reach a projected revenue of US$ 3,642.7 million by 2033. A compound annual growth rate of 15.8% is expected of South Korea cell culture market from 2026 to 2033.
In terms of revenue, South Korea accounted for 6.1% of the global cell culture market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China cell culture market is projected to lead the regional market in terms of revenue in 2033.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,028.2 million by 2033.
South Korea exhibits high potential for R&D capabilities in the pharmaceutical & biopharmaceutical sectors, which is expected to boost the demand for cell culture products for research purposes. Cancer research has become a national priority for the Korean government. The Korean government supports several universities, institutions, and researchers to facilitate cancer research activities, which is anticipated to create huge demand for cell culture products in the country.
Furthermore, increasing R&D investments by major pharmaceutical companies in South Korea are anticipated to create a lucrative environment for market growth. For instance, in June 2019, AstraZeneca announced it would spend USD 630 million on R&D in South Korea over the next 5 years.
Moreover, the local presence of key players and initiatives undertaken by them are increasing the country’s access to cell culture products. For instance, in November 2021, Sartorius announced investments worth around USD 300 million (EUR 270 million) to be invested through the end of 2024 for the expansion of its activities in the country.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cell Culture Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.77% in 2025.
Horizon Databook has segmented the South Korea cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2021 to 2033.
South Korea exhibits high potential for R&D capabilities in the pharmaceutical & biopharmaceutical sectors, which is expected to boost the demand for cell culture products for research purposes. Cancer research has become a national priority for the Korean government. The Korean government supports several universities, institutions, and researchers to facilitate cancer research activities, which is anticipated to create huge demand for cell culture products in the country.
Furthermore, increasing R&D investments by major pharmaceutical companies in South Korea are anticipated to create a lucrative environment for market growth. For instance, in June 2019, AstraZeneca announced it would spend USD 630 million on R&D in South Korea over the next 5 years.
Moreover, the local presence of key players and initiatives undertaken by them are increasing the country’s access to cell culture products. For instance, in November 2021, Sartorius announced investments worth around USD 300 million (EUR 270 million) to be invested through the end of 2024 for the expansion of its activities in the country.
South Korea Cell Culture Market Product Outlook (Revenue, USD Million , 2021-2033)
Consumables
Instruments
South Korea Cell Culture Market Application Outlook (Revenue, USD Million , 2021-2033)
Biopharmaceutical Production
Drug Development
Diagnostics
Tissue Culture & Engineering
Cell and Gene Therapy
Toxicity Testing
Other Applications
Reasons to subscribe to Cell Culture Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cell Culture Market Outlook databook
Our clientele includes a mix of Cell Culture Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Cell Culture Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Korea Cell Culture Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.